Search For Lab Tests Here

The Metabolic Syndrome & Glucose Control Panel evaluates key biomarkers—fasting glucose, insulin, lipids, and related metrics—to assess insulin resistance, glucose dysregulation, and cardiometabolic risk. This integrated panel helps clinicians identify metabolic syndrome early, monitor glycemic control, and guide interventions to reduce progression to type 2 diabetes and cardiovascular disease.

The Prediabetes & Insulin Resistance Essential Lab Panel includes 12 tests and 101 biomarkers to support a focused review of blood sugar, insulin resistance, inflammation, kidney and urine risk, cholesterol, thyroid function, liver function, vitamin D, magnesium, uric acid, and metabolic wellness markers. Includes A1c, insulin, CMP, lipid ratios, hs-CRP, urine albumin, urinalysis, TSH, vitamin D, magnesium, CBC, and uric acid.

The Prediabetes & Insulin Resistance Advanced Lab Panel includes 30 tests and 135 biomarkers to support deeper review of blood sugar, insulin resistance, insulin production, cardiometabolic risk, kidney and urine risk, fatty-liver context, thyroid contributors, inflammation, methylation, nutrients, and metabolic wellness markers. Includes A1c, insulin, C-peptide, ApoB, Lp(a), cystatin C, GGT, bilirubin, thyroid markers, B12, MMA, and OMEGACHECK™.

The Prediabetes & Insulin Resistance Comprehensive Lab Panel includes 38 tests and 149 biomarkers to support broad review of blood sugar, insulin resistance, beta-cell strain, adipose signaling, cardiometabolic risk, kidney and urine risk, fatty-liver context, thyroid contributors, inflammation, methylation, nutrients, and hormone/stress patterns. Includes A1c, insulin, C-peptide, proinsulin, leptin, adiponectin, ApoB, Lp(a), Cardio IQ™, and more.

The Triglyceride Driver Identification Panel combines triglycerides with apolipoprotein C-III testing to reveal not just elevated fat levels, but the underlying regulatory drivers. By identifying impaired triglyceride breakdown and clearance, this advanced blood panel provides deeper insight into cardiometabolic risk beyond standard lipid testing and supports more precise evaluation of persistent or unexplained triglyceride elevation.

The IGF Binding Protein 1 (IGFBP-1) Test measures IGFBP-1, a protein that regulates insulin-like growth factor (IGF) activity and reflects insulin sensitivity. Abnormal levels may indicate insulin resistance, type 2 diabetes risk, or metabolic syndrome. Doctors use this test to evaluate glucose regulation, investigate metabolic disorders, and support early detection of endocrine imbalances that affect growth, energy balance, and long-term health.

The Insulin Response to Glucose Test, 5 Specimens evaluates insulin secretion at fasting and multiple post-glucose solution intervals. This expanded assessment highlights beta-cell function, insulin sensitivity, and abnormalities in carbohydrate metabolism. Results offer valuable information on how the body clears glucose and help identify insulin resistance, metabolic dysfunction, and diabetes-related risks.

The Leptin Test measures leptin hormone levels in blood to evaluate metabolism, appetite regulation, and body fat balance. Abnormal levels may indicate obesity, metabolic syndrome, insulin resistance, or leptin deficiency. Doctors use this test to assess unexplained weight gain, difficulty losing weight, or potential endocrine disorders. It also supports research on energy balance, fertility, and overall metabolic health management.

The Cardio IQ™ Insulin Test measures fasting insulin levels in the blood to help evaluate insulin resistance, metabolic health, and risk for conditions like type 2 diabetes and cardiovascular disease. It provides insight into how the body regulates blood sugar and supports personalized risk assessment and treatment planning.

The Testosterone Free and Total Test measures total testosterone and free, bioavailable testosterone in blood for both men and women. It helps diagnose hormone imbalance, infertility, low libido, erectile dysfunction in men, irregular periods, or PCOS in women. Doctors also order it to assess fatigue, mood changes, or muscle weakness and to monitor hormone therapy. This test provides key insight into reproductive, endocrine, and overall metabolic health.

The Cardio IQ™ Diabetes and ASCVD Risk Panel with Scores measures advanced cardiovascular and metabolic markers to evaluate risk for atherosclerotic cardiovascular disease and type 2 diabetes. This panel includes lipid analysis, glucose-related biomarkers, and inflammation indicators, helping assess cardiometabolic health. Results provide clinicians with detailed scoring to identify patterns that may influence prevention and long-term disease management.

The NMR Lipoprotein Fractionation Test uses nuclear magnetic resonance to measure particle size and concentration of LDL, HDL, and VLDL cholesterol. Unlike a standard lipid panel, it provides detailed information on lipoprotein subfractions linked to cardiovascular risk. Doctors use this test to assess heart disease risk, guide cholesterol management, and monitor therapy effectiveness. It offers deeper insight into lipid metabolism and cardiovascular health.

The IGF Binding Protein 3 (IGFBP-3) Test measures IGFBP-3, the primary carrier of insulin-like growth factor 1 (IGF-1), to evaluate growth hormone activity. Abnormal levels may indicate growth disorders, pituitary dysfunction, or nutritional problems. Doctors use this test with IGF-1 to assess short stature, delayed or rapid growth, and monitor therapy for growth hormone deficiency or excess, supporting accurate diagnosis and treatment.